174 related articles for article (PubMed ID: 12536309)
21. Evaluation of a new LightCycler reverse transcription-polymerase chain reaction infectivity assay for detection of human parvovirus B19 in dry-heat inactivation studies.
Prikhod'ko GG; Vasilyeva I; Reyes H; Wong S; Brown KE; Jameson T; Busby TF
Transfusion; 2005 Jun; 45(6):1011-9. PubMed ID: 15935001
[TBL] [Abstract][Full Text] [Related]
22. Detection of the human Parvovirus B19 in nonimmune hydrops fetalis using immunohistochemistry and nested-PCR in formalin-fixed and paraffin-embedded placenta and fetal tissues.
Landolsi H; Yacoubi MT; Bouslama L; Lahmar A; Trabelsi A; Hmissa S; Aouni M; Korbi S
Pathol Biol (Paris); 2009 May; 57(3):e1-7. PubMed ID: 18243574
[TBL] [Abstract][Full Text] [Related]
23. In situ detection of B19 DNA in bone marrow of immunodeficient patients using a digoxigenin-labelled probe.
Gentilomi G; Zerbini M; Musiani M; Gallinella G; Gibellini D; Venturoli S; Re MC; Pileri S; Finelli C; La Placa M
Mol Cell Probes; 1993 Feb; 7(1):19-24. PubMed ID: 8384313
[TBL] [Abstract][Full Text] [Related]
24. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19.
Pankuweit S; Ruppert V; Eckhardt H; Strache D; Maisch B
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):344-7. PubMed ID: 16316398
[TBL] [Abstract][Full Text] [Related]
26. The spectrum of parvovirus b19 infection in a pediatric hemato-oncologic ward.
Lackner H; Sovinz P; Benesch M; Aberle SW; Schwinger W; Schmidt S; Strenger V; Pliemitscher S; Urban C
Pediatr Infect Dis J; 2011 May; 30(5):440-2. PubMed ID: 21502929
[TBL] [Abstract][Full Text] [Related]
27. Erythrovirus B19 infection in humans.
Kishore J; Kapoor A
Indian J Med Res; 2000 Nov; 112():149-64. PubMed ID: 12452123
[TBL] [Abstract][Full Text] [Related]
28. [Virus etiology of inflammatory cardiomyopathy].
Kandolf R
Dtsch Med Wochenschr; 2004 Oct; 129(41):2187-92. PubMed ID: 15457399
[TBL] [Abstract][Full Text] [Related]
29. Serologic and molecular detection of human Parvovirus B19 infection.
Peterlana D; Puccetti A; Corrocher R; Lunardi C
Clin Chim Acta; 2006 Oct; 372(1-2):14-23. PubMed ID: 16765338
[TBL] [Abstract][Full Text] [Related]
30. [Human parvovirus B19 infection in patients with hematologic disorders on chemotherapy].
Fujita H; Takada K; Kuremoto K; Ishimoto K; Sato N; Tsuji A; Yoshida H; Kaneko M; Hirai H; Yamaguchi T
Rinsho Ketsueki; 1993 Jan; 34(1):28-33. PubMed ID: 8450604
[TBL] [Abstract][Full Text] [Related]
31. Detection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma.
Li Y; Wang J; Zhu G; Zhang X; Zhai H; Zhang W; Wang W; Huang G
Am J Gastroenterol; 2007 Jul; 102(7):1489-98. PubMed ID: 17459020
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization.
Wang X; Zhang G; Liu F; Han M; Xu D; Zang Y
J Clin Virol; 2004 Sep; 31(1):20-4. PubMed ID: 15288609
[TBL] [Abstract][Full Text] [Related]
33. Parvovirus B19 infection in Taiwanese patients with hematological disorders.
Lee YM; Tsai WH; You JY; Ing-Tiau Kuo B; Liao PT; Ho CK; Hsu HC
J Med Virol; 2003 Dec; 71(4):605-9. PubMed ID: 14556276
[TBL] [Abstract][Full Text] [Related]
34. Parvovirus B19 infection associated with severe aplastic anemia in an immunocompetent patient.
Yetgin S; Cetin M; Ozyürek E; Aslan D; Uçkan D
Pediatr Hematol Oncol; 2004; 21(3):223-6. PubMed ID: 15202161
[TBL] [Abstract][Full Text] [Related]
35. Detection of parvovirus B19 in synovial fluids of patients with osteoarthritis.
Aslan B; Serin MS; Aslan G; Kalaci A; Yanat AN; Tezcan S; Emekdas G
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):381-5. PubMed ID: 18096351
[TBL] [Abstract][Full Text] [Related]
36. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult.
Lamparter S; Schoppet M; Pankuweit S; Maisch B
Hum Pathol; 2003 Jul; 34(7):725-8. PubMed ID: 12874772
[TBL] [Abstract][Full Text] [Related]
37. Persistent symptomatic parvovirus B19 infection with severe thrombocytopenia transmitted by red blood cell transfusion containing low parvovirus B19 DNA levels.
Nagaharu K; Sugimoto Y; Hoshi Y; Yamaguchi T; Ito R; Matsubayashi K; Kawakami K; Ohishi K
Transfusion; 2017 Jun; 57(6):1414-1418. PubMed ID: 28369973
[TBL] [Abstract][Full Text] [Related]
38. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
Gallinella G; Zuffi E; Gentilomi G; Manaresi E; Venturoli S; Bonvicini F; Cricca M; Zerbini M; Musiani M
J Med Virol; 2003 Sep; 71(1):135-9. PubMed ID: 12858419
[TBL] [Abstract][Full Text] [Related]
39. Childhood myocarditis and parvovirus B19 genotypes.
Dina J; Villedieu F; Labombarda F; Freymuth F; de la Gastine G; Jokic M; Vabret A
J Clin Virol; 2011 Jan; 50(1):61-4. PubMed ID: 20952249
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
